Skip to main content
Sammy Saab, MD, Gastroenterology, Los Angeles, CA

SammySaabMD

Gastroenterology Los Angeles, CA

Hepatology & Liver Transplantation

Associate Professor, Medicine, UCLA School of Medicine

Dr. Saab is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Saab's full profile

Already have an account?

  • Office

    200 UCLA Medical Plaza
    Suite 140
    Los Angeles, CA 90095
    Phone+1 310-794-7152
    Fax+1 310-794-1666

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1997 - 2000
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Internal Medicine, 1992 - 1995
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1993

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1994 - 2026
  • American Board of Internal Medicine Transplant Hepatology

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013
  • Top Doctors:Southern California Castle Connolly, 2012
  • Fellow (AGAF) American Gastroenterological Association, 2008
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Similar Sustained Virologic Response in Real-World and Clinical Trial Studies of Hepatitis C/Human Immunodeficiency Virus Coinfection 
    Scripps Conference Services & CME /Scripps Translational Science Institute (STSI), Los Angeles, Cali - 7/13/2013

Authored Content

  • Trends in the Burden of Chronic Liver Disease Among Hospitalized US AdultsApril 2020

Press Mentions

  • UCLA Program Improves Outcomes for Patients with Rare Liver Cancer
    UCLA Program Improves Outcomes for Patients with Rare Liver CancerFebruary 1st, 2022
  • Alcohol Abuse Agitated by COVID-19 Stirring Liver Concerns
    Alcohol Abuse Agitated by COVID-19 Stirring Liver ConcernsMay 15th, 2020
  • HCV Screening Risk Factors in Pregnant Women Need Updating
    HCV Screening Risk Factors in Pregnant Women Need UpdatingMarch 27th, 2020
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish